Equivalent whole brain dose for patients undergoing gamma knife for multiple lesions.

Introduction The advent of new radiosurgical technology has enabled the treatment of patients with larger numbers of brain metastases. At what point the whole brain doses delivered in single fraction radiosurgical treatment begin to approximate a fraction of whole brain radiotherapy is unknown. Measuring the equivalent whole-brain dose for multiple lesions may yield useful clinical insights. Methods Twelve representative patients were chosen from our institutional database, having undergone radiosurgery for multiple lesions. All patients were treated using the Leksell Gamma Knife Perfexion radiosurgical platform. The entire brain was contoured and mean whole brain dose (MWBD) was calculated. For each plan, all enhancing tumors were outlined and total volume of tumors recorded. Results A total of 33 treatments were administered. Three patients underwent radiosurgery a single time, one patient on two occasions, four patients on three occasions, and four patients on four occasions. Median number of lesions treated was 8 (range 1-41). Dose ranged from 18-22 Gy per lesion. The median MWBD per treatment was 1.4 Gy (range 0.2-7.6 Gy). Median total tumor volume was 4.3 cm3 (range 0.048 cm3-21.72 cm3). No patients with less than 25 lesions treated had a MWBD greater than 4 Gy. Total tumor volume was also associated with greater MWBD, albeit with a greater number of outliers. Conclusion Both tumor number and volume were associated with increased MWBD. Patients with greater than 25 lesions treated per session or cumulative tumor volumes greater than 10 cm3 had MWBD's greater than 4 Gy. Furthermore, tumor location and proximity to vital structures are equally important to consider, highlighting the need for individualized treatment planning.

[1]  J. Knisely,et al.  Survival and Intracranial Control of Patients With 5 or More Brain Metastases Treated With Gamma Knife Stereotactic Radiosurgery , 2013, American journal of clinical oncology.

[2]  J. Knisely,et al.  Role of stereotactic radiosurgery in patients with more than four brain metastases. , 2013, CNS oncology.

[3]  C. Gross,et al.  Radiosurgery alone for 5 or more brain metastases: expert opinion survey. , 2010, Journal of neurosurgery.

[4]  Y. Nakasu,et al.  [Multidisciplinary management of brain metastases]. , 2010, Gan to kagaku ryoho. Cancer & chemotherapy.

[5]  D. Kondziolka,et al.  The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline , 2009, Journal of Neuro-Oncology.

[6]  K. Hess,et al.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. , 2009, The Lancet. Oncology.

[7]  Hiroki Shirato,et al.  Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases: A Randomized Controlled Trial , 2007 .

[8]  Maria Werner-Wasik,et al.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial , 2004, The Lancet.

[9]  S. Nishio,et al.  Gamma Knife radiosurgery for numerous brain metastases: is this a safe treatment? , 2002, International journal of radiation oncology, biology, physics.

[10]  L D Lunsford,et al.  Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. , 1999, International journal of radiation oncology, biology, physics.

[11]  A. Markoe,et al.  Dose Volume Histogram Analysis of the Gamma Knife Radiosurgery Treating Twenty-Five Metastatic Intracranial Tumors , 1998, Stereotactic and Functional Neurosurgery.